Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

New standard of care for lung cancer patients with EGFR mutations

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 26.07.19
Views: 1599

Dr Gelenis Domingo - Memorial Healthcare System, Hollywood, FL, USA

Dr Gelenis Domingo speaks to ecancer at the 2019 ASCO Direct Highlights Symposium in Miami about the session discussing and summarising lung cancer updates from ASCO.

Dr Domingo highlights some of the abstracts and research areas she expects to be discussed, including the data supporting a new standard of care for treating lung cancer patients with epidermal growth factor receptor (EGFR) mutations.

Related videos


no rating
Epidemiology of cancer in India

follow us

Donate to ecancer

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation